Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sesderma Zinc Defense
- Development stage
- Phase 2
- Lead developer
- Sesderma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Sesderma Zinc Defense is an oral dietary supplement featuring liposomal zinc, developed by the Spanish dermatology company Sesderma. Zinc is an essential micronutrient that serves as a cofactor for over 300 enzymes and is vital for immune cell development and function, DNA synthesis, and antioxidant protection. The product utilizes Sesderma's proprietary liposomal encapsulation technology, which is intended to enhance the bioavailability of zinc and improve its absorption through the gastrointestinal tract while minimizing common side effects such as gastric irritation. In clinical settings, Zinc Defense has been investigated as a supportive therapy for viral infections, including COVID-19, due to zinc's ability to potentially inhibit viral RNA polymerase and modulate the inflammatory response.
- Brand names
- Sesderma Zinc DefenseZINC Defense
- Other names
- Sesderma Zinc Defense oral solutionLiposomal Zinc Defense
02
Targets
Misfolded SOD1RNAP (Bacterial dna-dependent RNA polymerase)
Beyond the preview
Go deeper on Sesderma Zinc Defense.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sesderma Zinc Defense.